In addition to global beneficial effects on adipose and insulin resistance, the most marked effect found for Parkin invalidation across aging was suppression of the age-related induction of FGF21, which was noted at the gene expression level in adipose tissues and liver, as well as for systemic FGF21 levels. The gene discussed is FGF21; the disease is Insulin resistance.